Total Payments
$5,920
2024 Payments
$840.60
Companies
28
Transactions
143
Medicare Patients
8,623
Medicare Billing
$767,691
Payment Breakdown by Category
Food & Beverage$5,920 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,920 | 143 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $989.17 | 12 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $676.62 | 20 | $0 (2021) |
| Medtronic Vascular, Inc. | $604.17 | 5 | $0 (2020) |
| Medtronic, Inc. | $501.50 | 4 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $410.50 | 15 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $309.47 | 16 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $288.95 | 8 | $0 (2021) |
| Boston Scientific Corporation | $266.39 | 5 | $0 (2024) |
| Amgen Inc. | $229.93 | 7 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $217.39 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $840.60 | 25 | Medtronic, Inc. ($257.56) |
| 2023 | $615.16 | 21 | Medtronic, Inc. ($150.13) |
| 2022 | $458.63 | 12 | Shockwave Medical, Inc ($182.68) |
| 2021 | $763.96 | 27 | Esperion Therapeutics, Inc. ($139.34) |
| 2020 | $351.82 | 9 | Medtronic Vascular, Inc. ($174.96) |
| 2019 | $959.63 | 17 | Medtronic Vascular, Inc. ($323.07) |
| 2018 | $640.95 | 11 | Abbott Laboratories ($229.61) |
| 2017 | $1,290 | 21 | Abbott Laboratories ($607.07) |
All Payment Transactions
143 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/03/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/17/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: DIABETES | ||||||
| 10/07/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $162.96 | General |
| Category: Renal Denervation System | ||||||
| 09/23/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $22.57 | General |
| Category: Cardiovascular | ||||||
| 09/17/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/28/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $31.45 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/27/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/08/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 07/29/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/19/2024 | Medtronic, Inc. | SELECTSECURE (Device) | Food and Beverage | In-kind items and services | $94.60 | General |
| Category: Leads | ||||||
| 06/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: DIABETES | ||||||
| 06/10/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/02/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: DIABETES | ||||||
| 05/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $113.82 | General |
| Category: DIABETES | ||||||
| 05/15/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/13/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Cardiology | ||||||
| 05/06/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/23/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $26.01 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 04/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: DIABETES | ||||||
| 04/16/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $56.03 | General |
| Category: Coronary | ||||||
| 01/12/2024 | Abbott Laboratories | — | Food and Beverage | In-kind items and services | $15.59 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,923 | 2,143 | $382,688 | $109,046 |
| 2022 | 27 | 1,956 | 2,333 | $686,330 | $160,200 |
| 2021 | 27 | 2,601 | 3,575 | $1.3M | $298,420 |
| 2020 | 25 | 2,143 | 2,747 | $870,047 | $200,025 |
Total Patients
8,623
Total Services
10,798
Medicare Billing
$767,691
Procedure Codes
107
All Medicare Procedures & Services
107 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 160 | 215 | $54,960 | $19,910 | 36.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 353 | 355 | $82,809 | $18,104 | 21.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 135 | 185 | $52,457 | $16,639 | 31.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 93 | 96 | $43,341 | $12,292 | 28.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 154 | 195 | $34,942 | $11,968 | 34.3% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 109 | 109 | $28,231 | $6,026 | 21.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 50 | 50 | $18,878 | $6,017 | 31.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 33 | 35 | $13,490 | $4,384 | 32.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 28 | 28 | $9,557 | $2,780 | 29.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 321 | 367 | $9,542 | $2,223 | 23.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 25 | $4,997 | $1,696 | 33.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 17 | 17 | $4,089 | $1,531 | 37.5% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 84 | 84 | $4,872 | $1,305 | 26.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 111 | 120 | $6,960 | $1,258 | 18.1% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 118 | 119 | $5,474 | $1,215 | 22.2% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 56 | 62 | $5,828 | $1,202 | 20.6% |
| 93272 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | Office | 2023 | 12 | 12 | $924.00 | $226.32 | 24.5% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 31 | 33 | $660.00 | $184.47 | 28.0% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 34 | 36 | $677.00 | $86.04 | 12.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 78 | 78 | $119,340 | $28,302 | 23.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 254 | 283 | $99,605 | $24,781 | 24.9% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2022 | 78 | 155 | $86,180 | $14,461 | 16.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 96 | 97 | $62,759 | $13,512 | 21.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 229 | 229 | $41,310 | $12,682 | 30.7% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2022 | 65 | 257 | $67,591 | $12,564 | 18.6% |
About Dr. Amol Bapat, M.D
Dr. Amol Bapat, M.D is a Interventional Cardiology healthcare provider based in Marietta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1316937378.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amol Bapat, M.D has received a total of $5,920 in payments from pharmaceutical and medical device companies, with $840.60 received in 2024. These payments were reported across 143 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($5,920).
As a Medicare-enrolled provider, Bapat has provided services to 8,623 Medicare beneficiaries, totaling 10,798 services with total Medicare billing of $767,691. Data is available for 4 years (2020–2023), covering 107 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Location Marietta, GA
- Active Since 10/21/2005
- Last Updated 03/07/2023
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1316937378
Products in Payments
- XARELTO (Drug) $676.62
- JARDIANCE (Drug) $368.95
- CareLink (Device) $340.12
- Xience Alpine cornary stent system (Device) $318.51
- LifeVest (Device) $288.95
- Azure (Device) $251.72
- PCI Optimization (Device) $234.88
- LOKELMA (Drug) $217.39
- Repatha (Biological) $213.30
- SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) $182.68
- ENTRESTO (Drug) $178.05
- ELIQUIS (Drug) $176.08
- SYMPLICITY G3 (Device) $162.96
- AMPLATZER Vascular Plugs (Device) $161.48
- AZURE XT DR MRI SURESCAN (Device) $150.13
- Inspire Upper Airway Stimulation System (Device) $135.77
- LEQVIO (Drug) $131.42
- VERQUVO (Drug) $124.66
- WATCHMAN DEVICE (Device) $118.41
- NEXLETOL (Drug) $112.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in Marietta
Dr. George Kramer, M.d, M.D
Interventional Cardiology — Payments: $109,834
Interventional Cardiology $109,834
Dhaval Patel, M.d, M.D
Interventional Cardiology — Payments: $72,112
Interventional Cardiology $72,112
John Goddard, M.d, M.D
Interventional Cardiology — Payments: $9,236
Interventional Cardiology $9,236
Nabil Sabbak, Md, MD
Interventional Cardiology — Payments: $5,272
Interventional Cardiology $5,272
Cheryl Robertson, M.d, M.D
Interventional Cardiology — Payments: $3,707
Interventional Cardiology $3,707
Jagdesh Kandala, Md, MD
Interventional Cardiology — Payments: $1,574
Interventional Cardiology $1,574